Literature DB >> 17123487

Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease.

Esther Pérez1, Marta Barrachina, Agustín Rodríguez, Benjamín Torrejón-Escribano, Mercé Boada, Isabel Hernández, Marisa Sánchez, Isidre Ferrer.   

Abstract

Abnormalities in the cerebral microvasculature are common in Alzheimer disease (AD). Expression levels of the water channels aquaporin 1 and aquaporin 4 (AQP1, AQP4) were examined in AD cases by gel electrophoresis and Western blotting, and densitometric values normalized with beta-actin were compared with corresponding values in age-matched controls processed in parallel. In addition, samples of cases with Pick disease (PiD) were examined for comparative purposes. A significant increase in the expression levels of AQP1 was observed in AD stage II (following Braak and Braak classification). Individual variations were seen in advanced stages which resulted in non-significant differences between AD stages V-VI and age-matched controls. No differences in AQP1 levels were observed between familial AD cases (FAD, all of them at advanced stages) and corresponding age-matched controls. Immunohistochemistry showed increased AQP1 in astrocytes at early stages of AD. Double-labelling immunofluorescence and confocal microscopy disclosed AQP1 immunoreactivity at the cell surface of astrocytes which were recognized with anti-glial fibrillary acidic protein antibodies. No differences in the levels of AQP4 were observed in AD, FAD and PiD when compared with corresponding controls. These results indicate abnormal expression of AQP1 in astrocytes in AD, and they add support to the idea that abnormal regulation of mechanisms involved in the control of water fluxes occurs at early stages in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123487     DOI: 10.1016/j.brainres.2006.09.109

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  41 in total

Review 1.  The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.

Authors:  Erin L Boespflug; Jeffrey J Iliff
Journal:  Biol Psychiatry       Date:  2017-12-07       Impact factor: 13.382

Review 2.  The Potential Roles of Aquaporin 4 in Alzheimer's Disease.

Authors:  Yu-Long Lan; Jie Zhao; Tonghui Ma; Shao Li
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

3.  Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy.

Authors:  Parham Moftakhar; Matthew D Lynch; Justine L Pomakian; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2010-12       Impact factor: 3.685

4.  Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.

Authors:  Amaryllis A Tsiknia; Steven D Edland; Erin E Sundermann; Emilie T Reas; James B Brewer; Douglas Galasko; Sarah J Banks
Journal:  Mol Psychiatry       Date:  2022-06-29       Impact factor: 15.992

5.  Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology.

Authors:  Joy G Mohanty; Hem D Shukla; Jefferey D Williamson; Lenore J Launer; Satya Saxena; Joseph M Rifkind
Journal:  Proteome Sci       Date:  2010-03-03       Impact factor: 2.480

6.  Aquaporins and glia.

Authors:  Roberta Albertini; Rossella Bianchi
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

7.  Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.

Authors:  Ian F Kimbrough; Stefanie Robel; Erik D Roberson; Harald Sontheimer
Journal:  Brain       Date:  2015-11-23       Impact factor: 13.501

8.  Neuronal Aquaporin 1 Inhibits Amyloidogenesis by Suppressing the Interaction Between Beta-Secretase and Amyloid Precursor Protein.

Authors:  Jinsu Park; Meenu Madan; Srinivasulu Chigurupati; Seung Hyun Baek; Yoonsuk Cho; Mohamed R Mughal; Amin Yu; Sic L Chan; Jogi V Pattisapu; Mark P Mattson; Dong-Gyu Jo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-01       Impact factor: 6.053

Review 9.  Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.

Authors:  Michelle A Erickson; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

10.  Aquaporin 1 - a novel player in spinal cord injury.

Authors:  O Nesic; J Lee; G C Unabia; K Johnson; Z Ye; L Vergara; C E Hulsebosch; J R Perez-Polo
Journal:  J Neurochem       Date:  2008-01-28       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.